Santen Pharmaceutical Co. Ltd. announced that Toshiaki Nishihata will retire from the position of Director and assume the position of Scientific Adviser.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,586 JPY | -2.40% | -3.35% | +12.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.88% | 3.71B | |
+48.53% | 780B | |
+41.30% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+17.58% | 244B | |
-1.10% | 217B | |
+11.39% | 214B | |
+4.40% | 161B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Santen Pharmaceutical Co. Ltd. Announces the Retirement of Toshiaki Nishihata as Director